Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy.

This publication has 19 references indexed in Scilit:

• Induction androgen deprivation plus prostatectomy for stage T3 disease: Failure to achieve prostate-specific antigen-based freedom from disease status in a phase II trial
  Urology, 1996
• Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.
  Journal of Clinical Oncology, 1996
• Conformal treatment of prostate cancer with improved targeting: Superior prostate-specific antigen response compared to standard treatment
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Joint statement of mission by the RTOG/EORTC working groups
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance?
  Urology, 1995
• Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.
  Journal of Clinical Oncology, 1995
• Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer
  Urology, 1993
• Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: Updated results of the RTOG 7704 randomized clinical trial
  The Prostate, 1987